Rethinking angiotensin receptor blocker (ARB) use in COVID-19: a class-wide call for careful dosing

Chia Siang Kow; Dinesh Sangarran Ramachandram; Syed Shahzad Hasan; Kaeshaelya Thiruchelvam

doi:10.1038/s41440-024-02055-1

Rethinking angiotensin receptor blocker (ARB) use in COVID-19: a class-wide call for careful dosing

Chia Siang Kow, Dinesh Sangarran Ramachandram, Syed Shahzad Hasan, Kaeshaelya Thiruchelvam

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	1254-1255
Number of pages	2
Journal	Hypertension Research
Volume	48
Issue number	3
Early online date	23 Dec 2024
DOIs	https://doi.org/10.1038/s41440-024-02055-1
Publication status	Published - 1 Mar 2025

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/s41440-024-02055-1Licence: Unspecified

Cite this

@article{beb53342ca2d422a834dfce53ee9472c,

title = "Rethinking angiotensin receptor blocker (ARB) use in COVID-19: a class-wide call for careful dosing",

keywords = "Angiotensin, Coronavirus, Hypotension, Valsartan",

author = "Kow, {Chia Siang} and Ramachandram, {Dinesh Sangarran} and Hasan, {Syed Shahzad} and Kaeshaelya Thiruchelvam",

year = "2025",

month = mar,

day = "1",

doi = "10.1038/s41440-024-02055-1",

language = "English",

volume = "48",

pages = "1254--1255",

journal = "Hypertension Research",

issn = "0916-9636",

publisher = "Nature Publishing Group",

number = "3",

}

TY - JOUR

T1 - Rethinking angiotensin receptor blocker (ARB) use in COVID-19

T2 - a class-wide call for careful dosing

AU - Kow, Chia Siang

AU - Ramachandram, Dinesh Sangarran

AU - Hasan, Syed Shahzad

AU - Thiruchelvam, Kaeshaelya

PY - 2025/3/1

Y1 - 2025/3/1

KW - Angiotensin

KW - Coronavirus

KW - Hypotension

KW - Valsartan

UR - http://www.scopus.com/inward/record.url?scp=85212853286&partnerID=8YFLogxK

U2 - 10.1038/s41440-024-02055-1

DO - 10.1038/s41440-024-02055-1

M3 - Letter

AN - SCOPUS:85212853286

VL - 48

SP - 1254

EP - 1255

JO - Hypertension Research

JF - Hypertension Research

SN - 0916-9636

IS - 3

ER -

Rethinking angiotensin receptor blocker (ARB) use in COVID-19: a class-wide call for careful dosing

UN SDGs

Access to Document

Other files and links

Cite this